Covestor’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Buy
129
+15
+13% +$1.27K 0.01% 1438
2026
Q1
$10K Sell
114
-42
-27% -$3.45K 0.01% 1399
2025
Q4
$14K Sell
156
-125
-44% -$12K 0.01% 1434
2025
Q3
$27K Sell
281
-56
-17% -$5.27K 0.01% 1164
2025
Q2
$35K Sell
337
-876
-72% -$83K 0.02% 1040
2025
Q1
$107K Sell
1,213
-279
-19% -$28.6K 0.07% 442
2024
Q4
$143K Sell
1,492
-32
-2% -$2.98K 0.09% 309
2024
Q3
$125K Buy
1,524
+328
+27% +$25.3K 0.08% 392
2024
Q2
$103K Sell
1,196
-2
-0.2% -$162 0.07% 466
2024
Q1
$98K Buy
1,198
+81
+7% +$6.32K 0.06% 550
2023
Q4
$74K Sell
1,117
-2
-0.2% -$139 0.05% 671
2023
Q3
$82K Buy
1,119
+539
+93% +$36.4K 0.06% 534
2023
Q2
$37K Buy
580
+413
+247% +$23.9K 0.03% 900
2023
Q1
$10K Buy
167
+1
+0.6% +$61 0.01% 1314
2022
Q4
$10K Sell
166
-9
-5% -$605 0.01% 1323
2022
Q3
$12K Sell
175
-5
-3% -$316 0.01% 1187
2022
Q2
$11K Buy
180
+168
+1,400% +$10.8K 0.01% 1175
2022
Q1
$1K Sell
12
-66
-85% -$3.56K ﹤0.01% 1845
2021
Q4
$3K Buy
+78
New +$4.54K ﹤0.01% 1472

Other funds holding HQY

Covestor's HQY Position: Q2 2026 in Review

Covestor increased its HealthEquity (HQY) stake by 13% in Q2 2026, buying an estimated $1.27K and bringing the position to 129 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #1438.

Covestor first reported a position in HQY in Q4 2021 and has held it in 19 quarters since. The position peaked at $143K in Q4 2024. 500 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Covestor held 129 shares of HealthEquity worth $12K as of Q2 2026.
  • Covestor bought 15 HealthEquity shares in Q2 2026, an estimated $1.27K.
  • HealthEquity made up 0.01% of Covestor's portfolio in Q2 2026, its #1438 holding.
  • Covestor first reported a position in HealthEquity in Q4 2021 and has held it in 19 quarters since.
  • Covestor's HealthEquity position peaked at $143K in Q4 2024.
  • 500 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.